Persistence Market Research
The demand within the global single-dose prefilled cartridges market has been rising on account of advancements in the field of healthcare diagnostics and treatment. The use of single-dose prefilled cartridges helps medical practitioners in administering the right amount of medicinal dosages. These cartridges can be customized according to the size of syringe, and help in ascertaining the amount of dosage to be administered. Hence, the global single-dose prefilled cartridges market is projected to grow at a stellar pace in the years to follow.
The right amount of dosage is extremely important because under-dosage or over-dosage can adversely affect the health of individuals. Therefore, the global single-dose prefilled cartridges market is projected to tread along a lucrative growth path in the years to follow.
Advent of new technologies within the field of medical dosage has played a vital role in the growth of the global single-dose prefilled cartridges market. The presence of a seamless industry for treatment of chronic diseases and disorders has also given a push to the growth of the global single-dose prefilled cartridges market. The field of paediatrics has especially emerged as a key consumer of single-dose prefilled cartridges in recent times.
On the basis of geography, the global single-dose prefilled cartridges market can be segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The market for single-dose prefilled cartridges in North America is expanding on account of the popularity of injections and syringes for various treatment lines. The single-dose prefilled cartridges market in Europe is also projected to earn stellar revenues.
Prefilled cartridges are medical devices that are designed to fit into specialized syringes, which are used to administer the fluid medication. The prefilled cartridges eliminates the use of traditional standard syringe, which the medical practitioners had to manually fill medication before administration. This has benefited the healthcare professionals in enabling accurate dose, pre-measured dose, decrease in misidentification, reduction in risk of microbial contamination, and lower the medical errors during drug administration. In addition, the prefilled cartridges provide patient safety by reducing the incidences of inadvertent needle sticks and exposure to toxic products during drawing of medications from vials. According to the World Health Organization Repot 2002, around 35 million healthcare workers experience percutaneous exposure incidences to infectious diseases every year due to needle stick injuries. The prefilled cartridges benefit the pharmaceutical companies owing to the minimizing drug waste, less need of overfilling and increasing product life span of the medication. In addition, the single dose prefilled cartridges mostly do not require preservatives which decreases the cost of the medication. These factors are increasing the popularity of single-dose prefilled cartridges, thereby driving the single-dose prefilled cartridges market. Moreover, the ease of self-administration of medication at home have increased the demand of prefilled cartridges among the patients.
The increase in chronic diseases such as diabetes, osteoarthritis, anemia, chronic pain and others fuel the market growth. According to Centers for Disease Control and Prevention (CDC), 2017, osteoarthritis affects around 30 million people in the U.S. In addition, the rise in geriatric population that are prone to various diseases intake multiple medication; which have fuel the single dose prefilled cartridges market. However, the availability of substitutes such as prefilled syringes, auto-injectors and pen injectors hinder the market growth. In addition, the pharmaceutical companies have to comply with the stringent needle stick injuries rules and regulations, which is anticipated to hinder the market growth. The ongoing research and development associated with the single-dose prefilled cartridges and increasing awareness of prefilled cartridges in undeveloped countries is anticipated to create new opportunities during the forecast period.
The global single-dose prefilled cartridges market is segmented on the basis of product type, application, and end user.
On the basis of product type, the global Single-dose prefilled cartridges market is segmented into:
On the basis of application, the global single-dose prefilled cartridges market is segmented into:
On the basis of end user, the global single-dose prefilled cartridges market is segmented into:
The global single-dose prefilled cartridges market is expected to register a significant CAGR over a forecast period. The increasing demand for single-dose prefilled cartridges owing to their advantages such as convenience, affordability, ease of use, accuracy, sterility and safety is anticipated to fuel the global Single-dose prefilled cartridges market. The increase in diseases and disorder and need of diagnosis and treatment is anticipated to drive the market growth. Furthermore, elimination of need of doctors and healthcare professionals in drug administration have escalated to adoption of prefilled cartridges, globally. The increasing adoption of single-dose prefilled cartridges among lower income groups from the developing regions such as Asia Pacific, is anticipated to propel the demand of the single-dose prefilled cartridges market.
However, the stringent government regulations associated with the needle stick injuries and no availability of prefilled cartridge with integrated safety features is anticipated to hamper the market growth. Furthermore, the increasing popularity of substitutes such as auto-injectors are hindering the single-dose prefilled cartridge market growth.
On the basis of regional presence, the global single-dose prefilled cartridges market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa.
The Europe is contributing the significant shares to the global single-dose prefilled cartridges market in terms of revenue and expected to register a significant growth over a forecast period due to developed medical infrastructure along with the large patient pool in the region. Asia Pacific also contributes lucrative market for single-dose prefilled cartridges devices and anticipated to register significant shares over the forecast period due to the increasing adoption of advanced single-dose prefilled cartridges devices and developing medical infrastructure in the region. The Latin America and MEA are at a nascent stage to the global single-dose prefilled cartridges market and expected to show a moderate growth over a forecast period due to increasing medical facilities in the region.
Some key companies covered in this report include Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc ., Mylan N.V., Pfizer, Inc., Fresenius Kabi AG, Novartis AG, Sanofi, Merck & Co. Inc. and others. The global Single-dose prefilled cartridges market is currently witnessing a number of strategic collaboration and partnership activities by manufacturers and end users.
The report covers exhaustive analysis on:
Regional analysis includes
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.